Your browser doesn't support javascript.
loading
Definition, criteria, and core concepts of guidelines for the management of obesity disease in Japan.
Ogawa, Wataru; Hirota, Yushi; Miyazaki, Shigeru; Nakamura, Tadashi; Ogawa, Yoshihiro; Shimomura, Iichiro; Yamauchi, Toshimasa; Yokote, Koutaro.
Affiliation
  • Ogawa W; Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
  • Hirota Y; Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
  • Miyazaki S; Center for Comprehensive Health Check and Promotion, Japan Anti-Tuberculosis Association, Tokyo 101-8372, Japan.
  • Nakamura T; Department of Internal Medicine, Kawasaki Hospital, Kobe 652-0042, Japan.
  • Ogawa Y; Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.
  • Shimomura I; Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Suita 565-0871, Japan.
  • Yamauchi T; Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan.
  • Yokote K; Department of Endocrinology, Hematology, and Gerontology, Chiba University Graduate School of Medicine, Chiba 260-8670, Japan.
Endocr J ; 71(3): 223-231, 2024 Mar 28.
Article in En | MEDLINE | ID: mdl-38123337
ABSTRACT
To identify those who might benefit from weight reduction within a large population of obese individuals, Japan Society for the Study of Obesity (JASSO) advocated the concept of "obesity disease." Here we summarize the definition, criteria, and core concepts for the management of obesity disease based on JASSO's latest guideline. JASSO defines obesity as excessive fat storage in adipose tissue associated with a BMI of ≥25 kg/m2. The threshold BMI of obesity is low as compared to Western countries given that Japanese individuals tend to develop obesity-related health disorders at lower BMI. Obesity with a BMI of ≥35 kg/m2 is referred to as "high-degree obesity" as treatment strategies vary based on the degree of obesity. Obesity is diagnosed as "obesity disease" if accompanied by any of the 11 specific obesity-related health disorders that weight reduction can prevent or alleviate, or if it meets the criteria for visceral fat obesity with a visceral fat area of ≥100 cm2. The initial weight reduction goals for high-degree obesity disease range from 5% to 10% of their current body weight, depending on the associated health disorders. That for those with obesity disease who do not qualify as high-degree is 3% or more. If these initial goals are not achieved, intensifying dietary therapy or introducing drug therapy (or both) may be necessary. While surgical treatment is primarily indicated for high-degree obesity disease, it might be appropriate for cases of obesity disease with a BMI <35 kg/m2, depending on the accompanying health disorders. Enhancing the quality of life for individuals with obesity or obesity disease necessitates a broader societal approach, emphasizing the resolution of related stigma.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quality of Life / Obesity Limits: Humans Country/Region as subject: Asia Language: En Journal: Endocr J Journal subject: ENDOCRINOLOGIA Year: 2024 Document type: Article Affiliation country: Japón

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quality of Life / Obesity Limits: Humans Country/Region as subject: Asia Language: En Journal: Endocr J Journal subject: ENDOCRINOLOGIA Year: 2024 Document type: Article Affiliation country: Japón